Dhanuka Agritech Limited (BOM:507717)

CTI BioPharma Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Operating Revenue	20,699	20,352	17,585	17,002	14,778	13,875
Other Revenue	9.09	-	-	-	-	-
Revenue	20,708	20,352	17,585	17,002	14,778	13,875
Revenue Growth (YoY)	9.97%	15.73%	3.43%	15.05%	6.51%	23.87%
Cost of Revenue	12,345	12,191	10,722	11,155	9,391	8,633
Gross Profit	8,363	8,161	6,864	5,848	5,387	5,242
Selling, General & Admin	1,955	1,917	1,745	1,442	1,352	1,314
Other Operating Expenses	2,108	2,069	1,839	1,556	1,385	1,237
Operating Expenses	4,649	4,540	3,989	3,173	2,899	2,702
Operating Income	3,714	3,621	2,874	2,674	2,488	2,539
Interest Expense	-55.81	-51.12	-30.87	-31.18	-32.03	-26.94
Interest & Investment Income	204.44	204.44	196.37	180.01	141.18	156.95
Currency Exchange Gain (Loss)	-9.59	-9.59	-5.5	-62.3	-13.82	25.24
Other Non Operating Income (Expenses)	75.03	75.03	54.89	7.94	55.95	4.85
EBT Excluding Unusual Items	3,928	3,840	3,089	2,769	2,639	2,699
Gain (Loss) on Sale of Investments	43.47	43.47	88.21	44.77	130.69	146.56
Gain (Loss) on Sale of Assets	37.8	37.8	8.94	214.62	6.24	2.28
Asset Writedown	-	-	-0.07	-1.33	-1.95	-
Other Unusual Items	0.32	0.32	1.2	0.22	1.82	1.14
Pretax Income	4,009	3,921	3,188	3,027	2,776	2,849
Income Tax Expense	973.75	951.8	796.62	692.19	687.01	743.77
Net Income	3,036	2,970	2,391	2,335	2,089	2,106
Net Income to Common	3,036	2,970	2,391	2,335	2,089	2,106
Net Income Growth	19.02%	24.20%	2.39%	11.78%	-0.79%	48.96%
Shares Outstanding (Basic)	45	45	46	46	47	47
Shares Outstanding (Diluted)	45	45	46	46	47	47
Shares Change (YoY)	-0.88%	-0.61%	-1.72%	-0.43%	-1.31%	-0.80%
EPS (Basic)	67.19	65.55	52.46	50.35	44.85	44.61
EPS (Diluted)	67.19	65.55	52.46	50.35	44.85	44.61
EPS Growth	20.07%	24.96%	4.19%	12.27%	0.53%	50.16%
Free Cash Flow	-	686.61	451.24	120.5	444.51	2,184
Free Cash Flow Per Share	-	15.16	9.90	2.60	9.54	46.28
Dividend Per Share	-	2.000	14.000	2.000	14.000	2.000
Dividend Growth	-	-85.71%	600.00%	-85.71%	600.00%	-83.33%
Gross Margin	40.38%	40.10%	39.03%	34.39%	36.45%	37.78%
Operating Margin	17.93%	17.79%	16.35%	15.73%	16.84%	18.30%
Profit Margin	14.66%	14.59%	13.60%	13.73%	14.14%	15.18%
Free Cash Flow Margin	-	3.37%	2.57%	0.71%	3.01%	15.74%
EBITDA	4,190	4,072	3,221	2,792	2,590	2,639
EBITDA Margin	20.24%	20.01%	18.32%	16.42%	17.53%	19.02%
D&A For EBITDA	476.59	450.62	346.73	117.18	102.6	99.31
EBIT	3,714	3,621	2,874	2,674	2,488	2,539
EBIT Margin	17.93%	17.79%	16.35%	15.73%	16.84%	18.30%
Effective Tax Rate	24.29%	24.27%	24.99%	22.87%	24.75%	26.10%
Revenue as Reported	21,069	20,713	17,935	17,450	15,114	14,212
Advertising Expenses	-	191.72	188.59	171.99	140.76	106.93

Source: S&P Global Market Intelligence. Standard template. Financial Sources.